|
US5892019A
(en)
|
1987-07-15 |
1999-04-06 |
The United States Of America, As Represented By The Department Of Health And Human Services |
Production of a single-gene-encoded immunoglobulin
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5573924A
(en)
|
1992-09-08 |
1996-11-12 |
Immunex Corporation |
CD27 ligand
|
|
DE19747418C1
(de)
|
1997-10-27 |
1999-07-15 |
Deutsches Krebsforsch |
Inhibitor-Protein des wnt-Signalwegs
|
|
US6500633B1
(en)
|
2000-04-26 |
2002-12-31 |
Atairgin Technologies, Inc. |
Method of detecting carcinomas
|
|
US20030148321A1
(en)
|
2001-08-24 |
2003-08-07 |
Iris Pecker |
Methods and kits for diagnosing and monitoring hematopoietic cancers
|
|
EP1470247A2
(en)
|
2001-11-05 |
2004-10-27 |
Deutsches Krebsforschungszentrum |
Novel genetic markers for leukemias
|
|
NZ533240A
(en)
|
2001-11-27 |
2007-12-21 |
Oxford Glycosciences Uk Ltd |
Use of polypeptide for the treatment of epithelial-derived cancer
|
|
US7261892B2
(en)
|
2001-11-27 |
2007-08-28 |
Celltech R&D Limited |
Methods for diagnosis and treatment of epithelial-derived cancers
|
|
US8404716B2
(en)
|
2002-10-15 |
2013-03-26 |
Celgene Corporation |
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
|
|
US8039218B2
(en)
|
2002-11-14 |
2011-10-18 |
John Wayne Cancer Institute |
Detection of cancer cells in body fluids
|
|
US7662387B2
(en)
|
2003-02-20 |
2010-02-16 |
Seattle Genetics |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
US20080025989A1
(en)
*
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
DE602004028347D1
(de)
|
2003-03-24 |
2010-09-09 |
Zymogenetics Inc |
Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
|
|
SG188175A1
(en)
|
2004-06-03 |
2013-03-28 |
Novimmune Sa |
Anti-cd3 antibodies and methods of use thereof
|
|
US7641903B2
(en)
|
2004-10-15 |
2010-01-05 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US8337838B2
(en)
|
2004-10-15 |
2012-12-25 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
WO2006044643A2
(en)
|
2004-10-15 |
2006-04-27 |
Seattle Genetics, Inc. |
Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
EA015706B1
(ru)
|
2004-10-22 |
2011-10-31 |
Займоджинетикс, Инк. |
Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
|
|
WO2006113747A2
(en)
|
2005-04-19 |
2006-10-26 |
Prediction Sciences Llc |
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
|
|
US8067546B2
(en)
|
2005-04-19 |
2011-11-29 |
Seattle Genetics, Inc. |
Humanized anti-CD70 binding agents and uses thereof
|
|
US20080280297A1
(en)
|
2005-07-15 |
2008-11-13 |
The Trustees Of Columbia University In The City Of |
Compositions and Methods for Differential Diagnosis of Chronic Lymphocytic Leukemia
|
|
EP1934261B1
(en)
|
2005-09-26 |
2014-10-29 |
Medarex, L.L.C. |
Human monoclonal antibodies to cd70
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
CN105837690A
(zh)
*
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
PL2099823T5
(pl)
|
2006-12-01 |
2023-02-20 |
Seagen Inc. |
Wariant środków wiążących cel i jego zastosowania
|
|
US20100150950A1
(en)
|
2006-12-14 |
2010-06-17 |
Medarex, Inc. |
Human antibodies that bind cd70 and uses thereof
|
|
KR100807069B1
(ko)
|
2007-09-21 |
2008-02-25 |
고려대학교 산학협력단 |
암 치료용 의약 조성물
|
|
AU2008324203A1
(en)
|
2007-11-05 |
2009-05-14 |
Novartis Ag |
Methods and compositions for measuring Wnt activation and for treating Wnt-related cancers
|
|
GB2461546B
(en)
|
2008-07-02 |
2010-07-07 |
Argen X Bv |
Antigen binding polypeptides
|
|
WO2010014948A1
(en)
|
2008-08-01 |
2010-02-04 |
The University Of Utah Research Foundation |
Methods of treatment using wnt inhibitors
|
|
WO2010019921A2
(en)
|
2008-08-15 |
2010-02-18 |
The Regents Of The University Of California |
Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia
|
|
EP2331136B1
(en)
|
2008-09-26 |
2018-01-10 |
OncoMed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
US8647623B2
(en)
|
2009-04-10 |
2014-02-11 |
Kyowa Hakko Kirin Co., Ltd |
Method for treatment of blood tumor using anti-TIM-3 antibody
|
|
ES2835553T3
(es)
|
2009-08-10 |
2021-06-22 |
Biosplice Therapeutics Inc |
Inhibidores de indazol de la vía de señalización de Wnt y sus usos terapéuticos
|
|
WO2011035433A1
(en)
|
2009-09-23 |
2011-03-31 |
University Health Network |
Selected strains on serum-free growth media for proteomics analysis of lung cancer biomarkers
|
|
MX2012005791A
(es)
|
2009-11-19 |
2012-07-03 |
Merck Serono Sa |
Anticuerpos humanizados contra el receptor alfa de la interleucina 22 humana.
|
|
AU2010339359A1
(en)
|
2009-12-29 |
2012-07-26 |
Kyowa Hakko Kirin Co., Ltd. |
Anti-CD27 antibody
|
|
GB2476681B
(en)
|
2010-01-04 |
2012-04-04 |
Argen X Bv |
Humanized camelid VH, VK and VL immunoglobulin domains
|
|
CN103079644B
(zh)
|
2010-06-11 |
2017-02-15 |
协和发酵麒麟株式会社 |
抗tim‑3抗体
|
|
JP5940093B2
(ja)
|
2011-01-19 |
2016-06-29 |
カンタージア アクチエボラーグ |
抗ｉｌ−１ｒａｐ抗体及びヒトを処置するためのそれらの使用
|
|
BR112013021562B1
(pt)
|
2011-03-16 |
2023-01-10 |
Argenx Bvba |
Anticorpos para cd70
|
|
WO2013006490A2
(en)
|
2011-07-01 |
2013-01-10 |
Cellerant Therapeutics, Inc. |
Antibodies that specifically bind to tim3
|
|
AP2014007588A0
(en)
|
2011-09-22 |
2014-04-30 |
Amgen Inc |
CD27L antigen binding proteins
|
|
WO2013093508A2
(en)
|
2011-12-22 |
2013-06-27 |
Oslo University Hospital Hf |
Wnt pathway inhibitors
|
|
JO3787B1
(ar)
|
2012-03-15 |
2021-01-31 |
Janssen Biotech Inc |
أجسام مضادة بشرية ضد cd27 و طرق و استخداماتها
|
|
US20150086521A1
(en)
|
2012-03-21 |
2015-03-26 |
Erytech Pharma |
Medicament for the Treatment of Acute Myeloid Leukemia (AML)
|
|
US9801851B2
(en)
|
2012-05-23 |
2017-10-31 |
St. Jude Children's Research Hospital |
Methods and compositions for the treatment of BCR-ABL positive lymphoblastic leukemias
|
|
RU2627712C2
(ru)
|
2012-06-15 |
2017-08-10 |
Кьюрдженикс Инк. |
Соединение как ингибитор передачи сигналов wnt, его композиции и применение
|
|
AU2013310924B2
(en)
|
2012-08-31 |
2017-08-03 |
Argenx Bvba |
Method for producing antibody molecules having inter-species, intra-target cross-reactivity
|
|
WO2014045101A1
(en)
|
2012-09-21 |
2014-03-27 |
Cellzome Gmbh |
Tetrazolo quinoxaline derivatives as tankyrase inhibitors
|
|
US20150315279A1
(en)
|
2012-12-21 |
2015-11-05 |
Cellerant Therapeutics, Inc. |
Antibodies that bind membrane-bound il1rap
|
|
DK2956173T3
(en)
|
2013-02-14 |
2017-07-17 |
Bristol Myers Squibb Co |
TUBULYSIS RELATIONSHIPS, METHODS OF PRODUCING AND USING THEREOF
|
|
PL3099717T3
(pl)
|
2014-01-31 |
2019-10-31 |
Novartis Ag |
Cząsteczki przeciwciała dla TIM-3 i ich zastosowanie
|
|
WO2015138600A2
(en)
*
|
2014-03-11 |
2015-09-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Anti sirp-alpha antibodies and bi-specific macrophage enhancing antibodies
|
|
US10391168B1
(en)
|
2014-08-22 |
2019-08-27 |
University Of Bern |
Anti-CD70 combination therapy
|
|
US20160200815A1
(en)
|
2015-01-05 |
2016-07-14 |
Jounce Therapeutics, Inc. |
Antibodies that inhibit tim-3:lilrb2 interactions and uses thereof
|
|
EA039859B1
(ru)
*
|
2015-07-31 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
|
TWI717375B
(zh)
*
|
2015-07-31 |
2021-02-01 |
德商安美基研究（慕尼黑）公司 |
Ｃｄ７０及ｃｄ３抗體構築體
|
|
WO2017044752A1
(en)
*
|
2015-09-10 |
2017-03-16 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Anti-fibrotic effect of cd70
|
|
PT3370768T
(pt)
|
2015-11-03 |
2022-04-21 |
Janssen Biotech Inc |
Anticorpos que se ligam especificamente ao pd-1 e seus usos
|
|
WO2017160954A1
(en)
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
GB2567613A
(en)
|
2017-06-16 |
2019-04-24 |
Argenx Bvba |
Treatment for acute myeloid leukaemia
|
|
GB201800649D0
(en)
|
2018-01-16 |
2018-02-28 |
Argenx Bvba |
CD70 Combination Therapy
|
|
TWI848030B
(zh)
|
2018-12-18 |
2024-07-11 |
比利時商阿根思公司 |
Ｃｄ７０組合治療
|
|
US20220136068A1
(en)
|
2019-03-06 |
2022-05-05 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods of detecting and treating venetoclax-resistant acute myeloid leukemia
|
|
MX2023002318A
(es)
|
2020-08-29 |
2023-05-19 |
argenx BV |
Metodo de tratamiento de pacientes con sensibilidad reducida a un inhibidor de bcl-2.
|
|
AU2021358768A1
(en)
|
2020-10-06 |
2023-05-18 |
The Regents Of The University Of Colorado, A Body Corporate |
Subject-specific treatments for venetoclax-resistant acute myeloid leukemia
|